Your browser doesn't support javascript.
loading
Donor to recipient age matching in lung transplantation: A European experience.
Pradere, P; Le Pavec, J; Morisset, S; Gerovasili, V; Kessler, R; Adlakha, A; Bunel, V; Santhanakrishnan, K; Demant, X; Roux, A; Falque, L; Cottin, V; Parmar, J; Reynaud-Gaubert, M; Villeneuve, T; Tissot, A; Mercier, O; Fisher, A J.
Afiliação
  • Pradere P; Pneumology Department, Marie Lannelongue Hospital, Le Plessis Robinson, France; Newcastle University Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle upon Tyne, United Kingdom. Electronic address: p.pradere@ghpsj.fr.
  • Le Pavec J; Pneumology Department, Marie Lannelongue Hospital, Le Plessis Robinson, France; Paris Saclay University, Faculty of Medical Sciences, Le Kremlin-Bicêtre, France; INSERM UMR-S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Hôpital Marie Lannelongue, Le Plessis Robinson, France.
  • Morisset S; Independent Biostatistician, Pérouges, France.
  • Gerovasili V; Transplant Department, Royal Brompton and Harefield Hospitals Guy's and St. Thomas' National Health Service Foundation Trust, London, United Kingdom; Imperial College London, Faculty of Medical Sciences, London, United Kingdom.
  • Kessler R; Groupe de Transplantation Pulmonaire des Hôpitaux Universitaires de Strasbourg, Inserm-Université de Strasbourg, Strasbourg, France.
  • Adlakha A; Transplant Department, Royal Free London NHS Foundation Trust, University Hospitals Birmingham, Birmingham, United Kingdom.
  • Bunel V; APHP, Nord-Université Paris Cité, Hôpital Bichat-Claude Bernard, Service de Pneumologie B et Transplantation Pulmonaire, Paris, France.
  • Santhanakrishnan K; Transplant Department, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
  • Demant X; Hôpital Haut-Lévêque, Service de pneumologie, CHU de Bordeaux, Bordeaux, France.
  • Roux A; Hôpital Foch, Service de pneumologie, Suresnes, France.
  • Falque L; Service Hospitalier Universitaire Pneumologie et Physiologie, Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, Grenoble, France.
  • Cottin V; Hospices Civils de Lyon, GHE, Service de Pneumologie, Inserm, Lyon, France.
  • Parmar J; Transplant Department, Royal Papworth Hospital, Cambridge, United Kingdom.
  • Reynaud-Gaubert M; CHU de Marseille, APHM, Hôpital Nord, Service de Pneumologie et Équipe de Transplantation pulmonaire; Aix-Marseille Université, Marseille, France.
  • Villeneuve T; CHU de Toulouse, Hôpital Larrey, Toulouse, France.
  • Tissot A; Nantes Université, CHU Nantes, Service de Pneumologie, Institut du thorax, Nantes, France.
  • Mercier O; Paris Saclay University, Faculty of Medical Sciences, Le Kremlin-Bicêtre, France; INSERM UMR-S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Hôpital Marie Lannelongue, Le Plessis Robinson, France; Thoracic Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, Le Ple
  • Fisher AJ; Newcastle University Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle upon Tyne, United Kingdom; Institute of Transplantation, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Article em En | MEDLINE | ID: mdl-38909711
ABSTRACT

BACKGROUND:

The age profile of organ donors and patients on lung transplantation (LT) waiting lists have changed over time. In Europe, the donor population has aged much more rapidly than the recipient population, making allocation decisions on lungs from older donors common. In this study we assessed the impact of donor and recipient age discrepancy on LT outcomes in the UK and France.

METHODS:

A retrospective analysis of all adult single or bilateral LT in France and the UK between 2010 and 2021. Recipients were stratified into 3 age author groups young (≤30 years), middle-aged (30-60) and older (≥60). Their donors were also stratified into 2 groups <60, ≥60. Primary graft dysfunction (PGD) rates and recipient survival was compared between matched and mismatched donor and recipient age groups. Propensity matching was employed to minimize covariate imbalances and to improve the internal validity of our results.

RESULTS:

Our study cohort was 4,696 lung transplant recipients (LTRs). In young and older LTRs, there was no significant difference in 1 and 5-year post-transplant survival dependent on the age category of the donor. Young LTRs who received older donor grafts had a higher risk of severe grade 3 PGD.

CONCLUSION:

Our findings show that clinically usable organs from older donors can be utilized safely in LT, even for younger recipients. Further research is needed to assess if the higher rate of PGD3 associated with use of older donors has an effect on long-term outcomes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article